- IP
Lab
Immunoprecipitation - Anti-eNOS antibody [EPR19296] - BSA and Azide free (AB240352)
This data was developed using ab199956, the same antibody clone in a different buffer formulation.
eNOS was immunoprecipitated from HUVEC (human umbilical vein endothelial cell) whole cell lysate 10 μg with ab199956 1/1000 dilution. Western blot was performed on the immunoprecipitate using ab199956 at 1/1000 dilution. Capture antibody, 1 : 30 dilution (2μg in 0.35mg lysates).
Rabbit monoclonal IgG (ab172730) Isotype Control was used instead of ab199956 in HUVEC (human umbilical vein endothelial cell) whole cell lysate (Lane 3).
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-eNOS antibody [EPR19296] (<a href='/ko/products/primary-antibodies/enos-antibody-epr19296-ab199956'>ab199956</a>) at 1/1000 dilution
All lanes:
HUVEC (human umbilical vein endothelial cell) whole cell lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/ko/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 140 kDa
false
Exposure time: 6s
- IP
Supplier Data
Immunoprecipitation - Anti-eNOS antibody [EPR19296] - BSA and Azide free (AB240352)
eNOS was immunoprecipitated from 1 mg of HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate with ab199956 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab199956 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HepG2 whole cell lysate 10 μg (Input).
Lane 2 : ab199956 IP in HepG2 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab199956 in HepG2 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab199956).
All lanes:
Immunoprecipitation - Anti-eNOS antibody [EPR19296] (<a href='/ko/products/primary-antibodies/enos-antibody-epr19296-ab199956'>ab199956</a>)
Predicted band size: 133 kDa
false
- IP
Lab
Immunoprecipitation - Anti-eNOS antibody [EPR19296] - BSA and Azide free (AB240352)
This data was developed using ab199956, the same antibody clone in a different buffer formulation.
eNOS was immunoprecipitated from mouse kidney tissue lysate 10 μg with ab199956 1/1000 dilution. Western blot was performed on the immunoprecipitate using ab199956 at 1/1000 dilution. Capture antibody, 1 : 30 dilution (2μg in 0.35mg lysates).
Rabbit monoclonal IgG (ab172730) Isotype Control was used instead of ab199956 in mouse kidney tissue lysate (Lane 3).
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-eNOS antibody [EPR19296] (<a href='/ko/products/primary-antibodies/enos-antibody-epr19296-ab199956'>ab199956</a>) at 1/1000 dilution
All lanes:
Mouse kidney tissue lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/ko/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 140 kDa
false
Exposure time: 41s
- IP
Lab
Immunoprecipitation - Anti-eNOS antibody [EPR19296] - BSA and Azide free (AB240352)
This data was developed using ab199956, the same antibody clone in a different buffer formulation.
eNOS was immunoprecipitated from rat kidney tissue lysate 10 μg with ab199956 1/1000 dilution. Western blot was performed on the immunoprecipitate using ab199956 at 1/1000 dilution. Capture antibody, 1 : 30 dilution (2μg in 0.35mg lysates).
Rabbit monoclonal IgG (ab172730) Isotype Control was used instead of ab199956 in rat kidney tissue lysate (Lane 3).
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-eNOS antibody [EPR19296] (<a href='/ko/products/primary-antibodies/enos-antibody-epr19296-ab199956'>ab199956</a>) at 1/1000 dilution
All lanes:
Rat kidney tissue lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/ko/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 140 kDa
false
Exposure time: 76s
- WB
Lab
Western blot - Anti-eNOS antibody [EPR19296] - BSA and Azide free (AB240352)
This data was developed using ab199956, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/1000,000 dilution.
Lysate was freshly made and used for Western blotting immediately to minimize protein degradation.
All lanes:
Western blot - Anti-eNOS antibody [EPR19296] (<a href='/ko/products/primary-antibodies/enos-antibody-epr19296-ab199956'>ab199956</a>) at 1/1000 dilution
Lane 1:
Frozen HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Fresh HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 140 kDa,36 kDa
false
Exposure time: 40s
- WB
Unknown
Western blot - Anti-eNOS antibody [EPR19296] - BSA and Azide free (AB240352)
Exposure Time : Lane1 : 40 seconds; Lane2 : 180 seconds
The expression profile observed in HeLa is consistent with the literature (PMID : 19925457).
Negative control : HeLa (PMID : 19925457)
All lanes:
Western blot - Anti-eNOS antibody [EPR19296] - BSA and Azide free (ab240352) at 1/1000 dilution
Lane 1:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 133 kDa
Observed band size: 140 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-eNOS antibody [EPR19296]
Reactivity 정보
제품 세부 정보
ab240352 is the carrier-free version of ab199956.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ENOS contributes significantly to the regulation of vascular tone and blood flow by promoting vasodilation. It does not function alone; instead it forms complexes with other proteins to exert its full effect. eNOS activity influences the process of angiogenesis inflammation modulation and platelet aggregation. Through its ability to produce nitric oxide eNOS acts as a signaling molecule helping maintain vascular homeostasis.
Pathways
ENOS is a critical player in the NO signaling pathway and interacts intricately with the PI3K/Akt pathway. Nitric oxide produced by eNOS has a role in signaling cascades that lead to vascular dilation and reduced blood pressure. The PI3K/Akt pathway regulates eNOS activity via phosphorylation enhancing NO production. Other proteins like caveolin-1 and calmodulin modulate eNOS impacting these pathways' outcomes.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (1)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Experimental dermatology 33:e15009 PubMed38284185
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com